Showing results (61-70 of 164) with videos related to

Sort By:
Pageof 17
Seminars in Oncology|February 1, 1996
A Phase I/II study of paclitaxel and doxorubicin in the treatment of advanced breast cancerD Amadori, G L Frassineti, W Zoli, et al.
The International Journal of Biological Markers|May 1, 1987
CEA levels in gastric juice in precancerous conditions and cancerD Amadori, A Ravaioli, R Biserni, et al.
European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Chromosomal alterations, biological features and in vitro chemosensitivity of SCLC-R1, a new cell line from human metastatic small cell lung carcinomaA Gasperi-Campani, L Roncuzzi, W Zoli, et al.
Breast Cancer Research and Treatment|April 1, 1997
Establishment and characterization of two new cell lines derived from human metastatic breast carcinomasW Zoli, L Roncuzzi, N Zini, et al.
International Journal of Cancer|February 6, 1999
Schedule-dependent interaction of doxorubicin, paclitaxel and gemcitabine in human breast cancer cell linesW Zoli, L Ricotti, F Barzanti, et al.
Tumori|October 31, 1986
Combination chemotherapy in advanced ovarian carcinomaD Amadori, A Ravaioli, M Maltoni, et al.
British Journal of Cancer|April 17, 1999
Physical activity and risk of cancers of the colon and rectum: an Italian case-control studyA Tavani, C Braga, C La Vecchia, et al.
Oncology (Williston Park, N.Y.)|April 1, 1997
Doxorubicin and paclitaxel (sequential combination) in the treatment of advanced breast cancerD Amadori, G L Frassineti, W Zoli, et al.
Journal of Clinical Pathology|August 30, 2005
Potential of telomerase expression and activity in cervical specimens as a diagnostic toolS Bravaccini, M A Sanchini, A Amadori, et al.
Breast Cancer Research and Treatment|April 1, 1995
In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancersW Zoli, A Flamigni, G L Frassineti, et al.
Pageof 17